Nanoligent
Nanoligent aim is the research and development to clinical phases of innovative cancer treatments based on protein nanoparticles.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Nanoligent Information
Geographic Data
Address: UAB Campus
City: Barcelona
State: barcelona
Zip: 08193
Country: ES
Financial Info
Stage:
seed
Raised Last:
$1M
Raised Total:$964k
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Nanoligent is a biotech company, spin-off of the Universitat Autònoma de Barcelona (UAB) and Institut de Recerca de l&s;Hospital de la Santa Creu I Sant Pau. We are dedicated to drug design and development of targeted-therapeutic biologics .Nanoligent mision is to improve the life of patients by designing new medicines that selectively target the cells affected by disease. With this approach we develope treatments that are more effective and have fewer adverse effects than classical drugs.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2022 | Seed | $963.9k |
i&i Biotech Fund |
9/2022 | Seed Round | $0 |
i&a;i Biotech Fund i&a;i Biotech Fund |
2/2022 | Seed Round | 2 | $1.1M |
AVANTECA Partners IAG Capital Partners AVANTECA Partners IAG Capital Partners |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
